KCND2 and epilepsy: In addition to miRNA antagonists mentioned above, miRNA antagonists which are mentioned above, studies have found that saikosaponin A may be a targeted treatment of KCND2-related epilepsy by upregulating Kchip1 and Kv4.2 expression, significantly reducing the frequency and duration of spontaneous recurrent seizures.